Literature DB >> 10886302

Immortalisation of human bone marrow endothelial cells: characterisation of new cell lines.

P M Rood1, J Calafat, A E von dem Borne, W R Gerritsen, C E van der Schoot.   

Abstract

BACKGROUND: Adhesion of haematopoietic progenitor cells (HPC) to human bone marrow endothelial cells (HBMEC) plays a key role in homing of HPC to bone marrow. Here we describe four new HBMEC cell lines that can be used to study the (specific) adhesion of HPC to HBMEC.
DESIGN: HBMEC were immortalised with a retroviral construct containing the human papilloma virus 16 E6/E7 genes. Four cell lines were characterised.
RESULTS: The cell lines showed their endothelial nature by the expression of von Willebrand Factor and VE-cadherin (CD144). Electron microscopic analysis revealed normal endothelial-cell characteristics, including the presence of Weibel-Palade bodies and intercellular junction structures. An extensive phenotypic analysis of the cell-lines was performed, they were found to resemble primary HBMEC. The only difference found was the absence of expression of E-selectin (CD62e) and VCAM-1 (CD106) on resting HBMEC cell lines. Upon stimulation with IL-1beta the expression of E-selectin, VCAM-1 and ICAM-1 (CD54) was upregulated. All resting cell lines bound CD34+ HPC. Adhesion was increased by addition of the phorbol ester PMA. Two cell lines showed increased binding upon IL-1beta prestimulation. Highest adhesion was observed after the combination of IL-1beta prestimulation of the endothelial cells and addition of PMA. Binding of CD34+ HPC to HBMEC was compared with the binding to human umbilical vein endothelial cell lines and to a human dermal microvascular endothelial cell line (HMEC-1). So far, we have only found relatively less binding of HPC to IL-1beta prestimulated HMEC-1 cells, which could be explained by a reduced induction of E-selectin and VCAM-1 upon IL-1beta stimulation of these cells.
CONCLUSION: The immortalised HBMEC cell lines have maintained their normal phenotype for the majority of characteristics examined. The expression of E-selectin and VCAM-1, which are not constitutively expressed on the cell lines, can be induced by stimulation of the endothelial cells with IL-1beta. The cell lines have furthermore maintained their capability to bind HPC. They will therefore be useful to investigate the interactions between HPC and HBMEC involved in homing of HPC.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10886302     DOI: 10.1046/j.1365-2362.2000.00672.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  24 in total

1.  Immortalized functional endothelial progenitor cell lines from umbilical cord blood for vascular tissue engineering.

Authors:  Praveen K Sobhan; Mahendra Seervi; Jeena Joseph; Saneesh Varghese; Prakash Rajappan Pillai; Divya Mundackal Sivaraman; Jackson James; Roshin Elizabeth George; K E Elizabeth; T R Santhoshkumar; M Radhakrishna Pillai
Journal:  Tissue Eng Part C Methods       Date:  2012-10-01       Impact factor: 3.056

2.  Identification of leukocyte E-selectin ligands, P-selectin glycoprotein ligand-1 and E-selectin ligand-1, on human metastatic prostate tumor cells.

Authors:  Charles J Dimitroff; Leyla Descheny; Natalia Trujillo; Robert Kim; Vuong Nguyen; Wei Huang; Kenneth J Pienta; Jeffery L Kutok; Mark A Rubin
Journal:  Cancer Res       Date:  2005-07-01       Impact factor: 12.701

3.  Proliferation status defines functional properties of endothelial cells.

Authors:  Christoph Lipps; Muhammad Badar; Milada Butueva; Tatyana Dubich; Vivek Vikram Singh; Sophie Rau; Axel Weber; Michael Kracht; Mario Köster; Tobias May; Thomas F Schulz; Hansjörg Hauser; Dagmar Wirth
Journal:  Cell Mol Life Sci       Date:  2016-11-16       Impact factor: 9.261

4.  Antimyeloma activity of the sesquiterpene lactone cnicin: impact on Pim-2 kinase as a novel therapeutic target.

Authors:  Karin Jöhrer; Marlene Obkircher; Daniel Neureiter; Johanna Parteli; Claudia Zelle-Rieser; Eva Maizner; Johann Kern; Martin Hermann; Frank Hamacher; Olaf Merkel; Nathalie Wacht; Christian Zidorn; Marcel Scheideler; Richard Greil
Journal:  J Mol Med (Berl)       Date:  2011-12-29       Impact factor: 4.599

5.  Definition of molecular determinants of prostate cancer cell bone extravasation.

Authors:  Steven R Barthel; Danielle L Hays; Erika M Yazawa; Matthew Opperman; Kempland C Walley; Leonardo Nimrichter; Monica M Burdick; Bryan M Gillard; Michael T Moser; Klaus Pantel; Barbara A Foster; Kenneth J Pienta; Charles J Dimitroff
Journal:  Cancer Res       Date:  2012-11-13       Impact factor: 12.701

6.  Inhibition of spontaneous breast cancer metastasis by anti-Thomsen-Friedenreich antigen monoclonal antibody JAA-F11.

Authors:  Jamie Heimburg; Jun Yan; Susan Morey; Olga V Glinskii; Virginia H Huxley; Linda Wild; Robert Klick; Rene Roy; Vladislav V Glinsky; Kate Rittenhouse-Olson
Journal:  Neoplasia       Date:  2006-11       Impact factor: 5.715

7.  ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis.

Authors:  Xin Lu; Qiongqing Wang; Guohong Hu; Catherine Van Poznak; Martin Fleisher; Michael Reiss; Joan Massagué; Yibin Kang
Journal:  Genes Dev       Date:  2009-07-16       Impact factor: 11.361

8.  Evidence of porcine and human endothelium activation by cancer-associated carbohydrates expressed on glycoproteins and tumour cells.

Authors:  Olga V Glinskii; James R Turk; Kenneth J Pienta; Virginia H Huxley; Vladislav V Glinsky
Journal:  J Physiol       Date:  2004-01-01       Impact factor: 5.182

9.  Analysis of physiologic E-selectin-mediated leukocyte rolling on microvascular endothelium.

Authors:  Georg Wiese; Steven R Barthel; Charles J Dimitroff
Journal:  J Vis Exp       Date:  2009-02-11       Impact factor: 1.355

10.  Diabetes causes bone marrow endothelial barrier dysfunction by activation of the RhoA-Rho-associated kinase signaling pathway.

Authors:  Giuseppe Mangialardi; Rajesh Katare; Atsuhiko Oikawa; Marco Meloni; Carlotta Reni; Costanza Emanueli; Paolo Madeddu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-01-10       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.